维普中文期刊产品整合服务
5篇 您的检索式:作者名="Dimitrios Chatzopoulos"
    题名 作者 年代 出处 被引量
1Potential implications of Helicobacter pylori-related neutrophil-activating protein显示文摘Helicobacter pylori (H.pylori) virulence factors promote the release of various chemoattractants/inflammatory mediators,including mainly the neutrophilattractant chemokine interleukin-8 and neutrophilactivating protein (NAP),involved in H.pylori-induced gastric pathologies.Co-administration of Chios mastic gum (CMG),which inhibits H.pylori NAP,with an H.pylori eradication regimen might add clinical benefits against H.pylori-related gastric pathologies,but possibly not CMG as main therapy.Although H.pylori NAP and other H.pylori-related cytotoxins [i.e.,vaculating cytotoxin (VacA)] appear to play a major role in generating and maintaining the H.pylori-associated gastric inflammatory response and H.pylori NAP is a promising vaccine candidate against H.pylori infection (H.pylori-I),concerns regarding its potential drawbacks,particularly neurogenic ones,due to possible crossmimicry,should be considered.Possible cross-mimicry between H.pylori NAP and/or bacterial aquaporin (AQP) and neural tissues may be associated with the anti-AQP-4 antibody-related neural damage in multiple sclerosis (MS)/neuromyelitis optica patients.Moreover,the sequence homology found between H.pylori VacA and human Na+/K+-ATPase A subunit suggests that antibodies to VacA involve ion channels in abaxonal Schwann cell plasmalemma resulting in demyelination in some patients.A series of factors have been implicated in inducing blood-brain barrier (BBB) disruption,including inflammatory mediators (e.g.,cytokines and chemokines induced by H.pylori-I) and oxidative stress.BBB disruption permits access of AQP4-specific antibodies and T lymphocytes to the central nervous system,thereby playing a major role in multiple sclerosis pathogenesis.Relative studies show a strong association between H.pylori-I and MS.H.pylori-I induces humoral and cellular immune responses that,owing to the sharing of homologous epitopes (molecular mimicry),cross-react with components of nerves,thereby contributing and perpetuating neural tissue damage.Finally,H.pylori NAP also plays a possible pathogenetic role in both gastric and colon oncogenesis.Jannis Kountouras Christos Zavos Georgia Deretzi Emmanuel Gavalas Dimitrios Chatzopoulos Panagiotis Katsinelos Elena Tsiaousi Stergios Gagalis Stergios A Polyzos Ioannis Venizelos 2012World Journal of Gastroenterology2012,18,5:5
2Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease显示文摘Jannis Kountouras Marina Boziki Emmanuel Gavalas Christos Zavos Nikolaos Grigoriadis Georgia Deretzi Dimitrios Tzilves Panagiotis Katsinelos Magda Tsolaki Dimitrios Chatzopoulos Ioannis Venizelos 2009Journal of Neurology2009,,5:2
3Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease显示文摘Jannis Kountouras Marina Boziki Emmanuel Gavalas Christos Zavos Georgia Deretzi Nikolaos Grigoriadis Magda Tsolaki Dimitrios Chatzopoulos Panagiotis Katsinelos Dimitrios Tzilves Athina Zabouri Ifigenia Michailidou 2009International Journal of Neuroscience2009,,6:1
4Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett’s oesophagus显示文摘Jannis Kountouras Dimitrios Chatzopoulos Christos Zavos 2006Medical Hypotheses2006,,5:1
5Coronary stent fracture in an octogenarian patient:from bad to worse显示文摘Stent fracture represents a rare cause of stent failure especially in the era of new genera-tion coronary drug-eluting stents(DES).It is described as the interruption of stent continuity resulting in increased risk of in-stent restenosis and stent thrombosis and predisposes to repeat revascu-larization.[1]Although a growing number of octo-genarians benefit today from an invasive treatment of coronary artery disease(CAD),this benefit could be lost in frail patients with multiple comorbidities.[2]Octogenarians constitute a high-risk population in whom frailty and multiple comorbidities mandate for careful treatment planning.Andreas S.Triantafyllis Petros N.Fountoulakis Georgios Charalampidis Konstantinos Kotinas Pavlos Tsinivizov Dimitrios Varvarousis Andreas Giannakopoulos Sofia Apollonatou Areti Stefanidou Stamatios Chatzopoulos Dimitrios Tsiptsios Konstantinos Tsamakis Konstantinos Kyfnidis Leonidas E.Poulimenos 2021Journal of Geriatric Cardiology2021,18,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费